TelyRx Holdings Inc.TSX: TELY

TelyRx to Host Third Quarter 2026 Financial Results Conference Call on Friday, November 6, 2026 at 8: 30 am ET

· Issued by TelyRx Holdings Inc. via Newsfile

Summary by 6ix AI

TelyRx Holdings Inc., a healthcare and pharmacy services company, will host a conference call and webcast to discuss its third quarter 2026 financial results on Friday, November 6, 2026, at 8:30 a.m. Eastern Time (ET).

Key details

  • TelyRx expects to report its results for the period ended September 30, 2026, in a news release after market close on Thursday, November 5, 2026.
  • The call can be joined by phone at 1-833-752-3490 or 1-647-260-0811, and a live webcast will also be available.

6ix AI wrote this summary from the release below and checked it against the release.

Clearwater, Florida--(Newsfile Corp. - October 22, 2026) - TelyRx Holdings Inc. (TSX: TELY) (OTCQX: TELYF) ("TelyRx" or the "Company"), a vertically integrated, technology-enabled healthcare and pharmacy services company, today announced it will host a conference call and webcast to discuss its third quarter 2026 financial results on Friday, November 6, 2026, at 8:30 a.m. Eastern Time (ET). The Company expects to report its third quarter 2026 financial results for the period ended September 30, 2026, via news release after market close on Thursday, November 5, 2026.

Telephone Dial-In Access Information

The Company will host a conference call to discuss its third quarter 2026 financial results on Friday, November 6, 2026, at 8:30 a.m. Eastern Time (ET). To dial direct and enter the call through an operator, dial 1-833-752-3490 or 1-647-260-0811. The live webcast can be accessed by copying and pasting this link into a browser: https://www.gowebcasting.com/15175. Please connect approximately 15 minutes prior to the beginning of the webcast or call to ensure participation.

About TelyRx Holdings Inc.

TelyRx is an integrated digital healthcare platform that makes everyday prescription medications easier to access. Patients connect with independent, state-licensed healthcare providers who evaluate their needs and prescribe treatment when appropriate. Prescriptions are filled by TelyRx's licensed pharmacies and delivered directly to patients' doors. Serving patients across 48 U.S. states and all territories, TelyRx provides access to more than 500 common, FDA-approved medications for over 60 common health conditions through a seamless, convenient experience.

For additional information, visit www.telyrx.com or contact:

Neil Weber
Investor Relations
(647) 222-0574
investors@telyrx.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/320240

View original source (Newsfile)TelyRx Holdings Inc. on 6ix

Earlier from TelyRx

All TelyRx news releases